Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, in collaboration with Diazyme Laboratories, Inc. is offering three new Microtip Partnership Assays to their...
Medical device startup HeartHero announced today that it has raised a USD 1.5 million seed round investment from a venture capital firm, angel investors and grant funding. Initial...
Precision Therapeutics Inc., a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that on July 11, 2018 the...
Driven by booming strong internal growth and medical tourism, the pharmaceutical market in Thailand is projected to witness a compound annual growth rate (CAGR) of 10...
Abbott announced it received approval from the US Food and Drug Administration (FDA) for a next-generation version of its leading MitraClip heart valve repair device used to...
Bruker Corporation announced that it has acquired JPK Instruments AG (JPK), located in Berlin, Germany. In 2017, JPK Instruments had revenue of approximately 10 million Euro. JPK provides...
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its Board of Directors has declared a quarterly cash dividend of USD 0.17 per common share,...
Johnson & Johnson issued the following statement regarding today’s verdict in the St. Louis court. “Johnson & Johnson is deeply disappointed in the verdict, which was the product...
Luminex Corporation announced that it expects to report results for the second quarter ended June 30, 2018 on Monday, August 6, 2018. A press release announcing the results is...
Roche announced that it has received clearance from the US Food and Drug Administration (FDA) for the expanded use of its Elecsys B·R·A·H·M·S PCT assay to...
Amgen and UCB (Euronext Brussels: UCB) announced the resubmission of the Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for EVENITY (romosozumab),...
The US Food and Drug Administration is alerting healthcare professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used...
Astellas Pharma Inc. and Pfizer Inc. announced the US Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for XTANDI (enzalutamide), following FDA Priority...
Medtronic plc has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device...
Qiagen N.V. announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, UK, for innovation, life sciences, translational science and molecular...
Copyright © 2024 Medical Buyer